Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence
17 Jun 2011
Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence
ASCO 2011 highlights
Antiviral drugs as a radiosensitizer in HPV related tumours
Reducing global cancer mortality
The Cancer Genome Atlas (TCGA)
Chronic stress of cancer causes accelerated telomere shortening
Ovarian cancer patients with BRCA mutations show improved survival
Effects of stress on cancer progression
Ovarian cancer patients with BRCA mutations show improved survival
Recurrent ovarian cancer treatment practices
New system of staging for gynaecological cancers
Treatment of elderly gynaecological cancer patients